The hospitals that feature a movie theater for patients
Mariah Taylor / beckershospitalreview - In Britain, nine hospitals have a movie theater inside their facilities for patients to watch the latest blockbusters, The New York Times reported July 8. The theaters are created and operated by nonprofit MediCinema. The cinema has 40 seats, including sp…
AI Summary: Several hospitals have installed on‑site movie theaters and screening spaces to improve patient experience, reduce isolation and offer a pleasant distraction during long stays. Administrators pitch these cinemas as low‑tech, high‑mood medicine; skeptics raise budgetary eyebrows. For patients, though, a dimmed lights screening beats another fluorescent corridor any day.
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Frank Vinluan / medcitynews - Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currently available ADCs as well as those still in clinical development. The post A…
AI Summary: Novartis has struck a roughly $1 billion deal to acquire Myricx Bio, a preclinical bet aimed at securing a novel antibody‑drug conjugate payload. The move is a clear attempt to stand out in a crowded oncology market by buying potential innovation rather than inventing it in‑house — or, as finance folks call it, buying optionality.
IKS Health completes $557M TruBridge acquisition
Andrew Cass / beckershospitalreview - IKS Health has completed its $557 million acquisition of TruBridge, which provides revenue cycle management and EHR services for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health, according…
AI Summary: IKS Health has closed a $557 million deal to acquire TruBridge, integrating the acquired firm’s revenue-cycle and IT capabilities into IKS’s technology stack. The purchase accelerates IKS’s push to expand managed services for health systems, promising greater scale and product consolidation—because nothing says progress like buying your way into the future.
Tampa General sues Eli Lilly over pulled 340B discounts
Ella Jeffries / beckershospitalreview - Tampa General (Fla.) Hospital has sued Eli Lilly and Lilly USA, alleging the drugmaker’s decision to cut off the hospital’s 340B pricing access violates Florida’s Deceptive and Unfair Trade Practices Act. According to the July 2 complaint, filed in the U.…
AI Summary: Tampa General Hospital has filed suit against Eli Lilly after the company suspended discounts tied to the 340B drug-pricing program, alleging the move harmed hospitals that rely on those savings to fund patient care. The litigation highlights ongoing tensions over manufacturer discount policies and financial pressures on safety-net providers.
Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
fiercehealthcare - Health tech startup Pearl Health raised $110 million in a mix of debt and equity financing to build out its artificial intelligence platform for Medicare providers, including AI agents to handle administrative tasks.
AI Summary: Pearl Health secured $110 million in new funding to expand its technology and AI offerings for Medicare providers, aiming to boost value-based care infrastructure and support clinicians serving older patients. The cash infusion targets product development and market growth—because nothing scales value-based care like another round of venture capital.
Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
Susan Jaffe / kffhealthnews - Thousands of people who had a Medicare drug plan with zero-dollar premiums last year got small premium increases this year — and didn’t know it. They were dropped from their coverage for failing to pay amounts as little as $8, and most can’t get it again …
AI Summary: Investigations reveal that many Medicare beneficiaries who believed their drug coverage was free later discovered they had lost benefits, often because of plan changes or confusing enrollment processes. The situation exposed gaps in consumer communication and program oversight, prompting calls for clearer disclosures and stronger safeguards to prevent future coverage surprises.